Capsaicin

CHEMBL294199 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
305.4 g/mol
LogP
3.6
Phase
4

The active compound in chili peppers used topically and in patch form to relieve pain associated with conditions including neuropathy, arthritis, and post-herpetic neuralgia. It works by initially stimulating and then desensitizing pain-sensing nerve fibers through depletion of substance P and transient TRPV1 receptor overstimulation. Initial burning or stinging at the application site is common.

分子量

305.4000 g/mol

LogP

3.60

TPSA

58.60 Ų

リピンスキーの五則

適合

治療領域

作用機序

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O

InChI

InChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6+

Molecular Formula

C18H27NO3

HBD / HBA

2 / 3

回転可能結合数

9

重原子数

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The active compound in chili peppers used topically and in patch form to relieve pain associated with conditions including neuropathy, arthritis, and post-herpetic neuralgia. It works by initially stimulating and then desensitizing pain-sensing nerve fibers through depletion of substance P and transient TRPV1 receptor overstimulation. Initial burning or stinging at the application site is common.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Capsaicin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL294199. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 1548943. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.